Post Profile

Cell Design Labs, Little Partner Of Kite Pharma, Pushes T-Cell Engineering Frontier

Shutterstock Engineered T-cells are powerful emerging tools of cancer treatment. But scientists are still very much trying to figure out how to best keep these powerful cancer-killing cells from proliferating to dangerous excesses, keeping them concentrated around the tumor and expanding the range of molecular targets they can be directed against. It’s [...]
read more


Related Posts

Mayo Clinic researchers find lung cancer oncogene holds key to turning off cancer stem cells

Health : Newswise Medical News

Scientists at the Mayo Clinic campus in Florida have found that the lung cancer oncogene PKCiota is necessary for the proliferation of lung cancer stem cells. These stem cells are rare and powerful master cells that manufacture the ...

Researchers fabricate microfibers for single-cell studies, tissue engineering

Academics / Chemistry : Physorg: Chemistry

Iowa State University researchers have created a new way to design and fabricate microfibers that support cell growth and could be useful tools for reconnecting nerves and regenerating other damaged tissues.

Safety data support human testing of hematopoietic stem cell gene therapy for mucopolysaccharid I

Health : EurekAlert: Health

(Mary Ann Liebert, Inc./Genetic Engineering News) Extensive biosafety studies of hematopoietic stem cell (HSC) gene therapy, intended to replace a protein that patients with the inherited disease mucopolysaccaridosis I (MPS I) canno...

FASTER, PLEASE: Cancer cell therapies could be approved next year: Juno, Kite Pharma. A new wav…

US Politics / Conservative : Instapundit

FASTER, PLEASE: Cancer cell therapies could be approved next year: Juno, Kite Pharma. A new wave of experimental cancer drugs that directly recruit the immune system’s powerful T cells could begin reaching patients next year, accord...

New research may expand engineered T-cell cancer treatment

Academics / General Science : ScienceDaily: Science Society

Researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue. The scientists designed genetically engineered CAR T cells that must be activated and targeted by a small molecule adaptor. The tec...


Copyright © 2016 Regator, LLC